The joint effects of the two FAS polymorphisms on risk of CRC were more pronounced among the subgroups with age >60 years, female, never smokers, never drinkers, having no family history of cancer, and CRC with intermediate grade and with Dukes C and D stage. This evidence concerns the gene FAS and colorectal carcinoma.